Devises / BIIB
BIIB: Biogen Inc
126.64
USD
1.92
(1.49%)
Le taux de change de BIIB a changé de -1.49% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 125.97 et à un maximum de 129.62.
Suivez la dynamique Biogen Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BIIB Nouvelles
- Seeking Alpha Alkermes: A More Than Solid Quarter (NASDAQ:ALKS)
- Investing Apple, Amazon, Kla-tencor set to report earnings Thursday
- Investing Lecanemab real-world study shows promising results in early Alzheimer’s
- Zacks Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Investing Biotech stocks dip as Trump administration mulls patent fee overhaul
- Zacks Biogen Gears Up to Report Q2 Earnings: Here's What to Expect
- Zacks BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
- Zacks Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
- TipRanks QQQ ETF News, 7/24/2025 - TipRanks.com
- Benzinga Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
- Benzinga FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division - Sarepta Therapeutics (NASDAQ:SRPT), Biogen (NASDAQ:BIIB)
- Investing BMO Capital reiterates Eli Lilly stock rating with $900 price target
- Zacks How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
- TipRanks QQQ ETF News, 7/22/2025 - TipRanks.com
- Benzinga Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing - Biogen (NASDAQ:BIIB)
- Seeking Alpha Eli Lilly: Competition Melts Away (NYSE:LLY)
- Investing Truist Securities initiates Biogen stock coverage with Hold rating
- Investing Biogen to invest $2 billion more in North Carolina
- Investing Biogen to invest $2 billion in North Carolina manufacturing expansion
- Investing Harrow Health stock outlook strong as Cantor reiterates Overweight rating
- Investing Ionis Pharma CEO Monia sells $48,416 in stock
- Benzinga Is Bristol-Myers Squibb Still An Undervalued Biopharma Play? - Bristol-Myers Squibb (NYSE:BMY)
- Investing Biogen stock price target raised to $130 from $119 at UBS on Alzheimer’s outlook
- Seeking Alpha Patient Capital Management Q2 2025 Investment Review
Range quotidien
125.97
129.62
Range Annuel
110.03
219.44
- Clôture Précédente
- 127.90
- Ouverture
- 128.56
- Bid
- 126.64
- Ask
- 126.94
- Plus Bas
- 125.97
- Plus Haut
- 129.62
- Volume
- 4.221 K
- Changement quotidien
- -1.49%
- Changement Mensuel
- 1.26%
- Changement à 6 Mois
- -11.29%
- Changement Annuel
- -41.23%
30 juillet, mercredi
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- 7.698 M
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- 0.690 M
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- 1.317 M
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- 0.130 M
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- 3.635 M
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- 0.676 M
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- 0.739 M
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- -2.724 M
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- -0.025 M
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- -0.1%
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- 4.50%
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev